Indian stock markets present attractive opportunities now. Investors with an 18-month outlook should consider deploying funds, especially i...

India's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. ...

Unlike traditional ultrasound machines that rely on expensive piezoelectric ⁠crystals, Butterfly's ⁠device uses a single silicon chip for w...

Cipla has launched a new orally inhaled insulin powder for diabetes patients in India. This needle-free alternative to injections offers a ...

Zydus Lifesciences is innovating a single-device for semaglutide. This device can deliver multiple strengths of the drug. It targets both d...

By leveraging this technology, Lupin expects to provide healthcare professionals with alternative solutions for delivering affordable inhal...

{image_1} Concept Medical Inc CMI has been granted ‘Breakthrough Device Designation’ from the US Food and Drug Administration FDA for Magic...

The device was effective in improving cardiac function after a heart attack.

"The public will be advised, in their own interest, not to use any such products, sold or marketed in any form and under any name or brand,...

The ministry’s Central Drugs Standard Control Organisation (CDSCO) recently notified that it was revisiting the existing Act and Rules.

Medical devices industry has the potential to touch USD 30 billion mark in the next ten years if proper regulatory framework is provided.

The agreement grants Lupin exclusive rights to promote, distribute and market InspiraChamber VHC in the US, it added.

The company that sells a range of medicines and drug delivery devices in the diabetes segment is awaiting regulatory approval for the new p...

Drug firm ELi Lilly and Company today announced the launch of new drug administering device, used in the treatment of patient suffering fro...

Ranbaxy Laboratories is planning a new growth hormone product to target the emerging global market for new versions of patent-expired biote...

Biocon Limited, the country's leading biotechnology company, today announced the launch of a new drug delivery system, a pre-filled safety ...

Relisys Medical Devices is the only domestic manufacturer of coronary stents, devices that help clear blocks in blood vessels.